These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28043604)

  • 21. Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan.
    Akhmetova A; Kozhamkulov U; Bismilda V; Chingissova L; Abildaev T; Dymova M; Filipenko M; Ramanculov E
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):179-84. PubMed ID: 25574916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Diversity and Drug Susceptibility Profiles of Multidrug-Resistant Tuberculosis Strains in Southeast China.
    Lin S; Wei S; Zhao Y; Dai Z; Lin J; Pang Y
    Infect Drug Resist; 2021; 14():3979-3989. PubMed ID: 34611415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.
    Kim HJ; Kwak HK; Lee J; Yun YJ; Lee JS; Lee MS; Min SY; Park SK; Kang HS; Maeng YH; Kim SY; Kim SY; Kook YH; Kim YR; Lee KH
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):98-103. PubMed ID: 22236853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility.
    Zhang Y; Chiu Chang K; Leung CC; Wai Yew W; Gicquel B; Fallows D; Kaplan G; Chaisson RE; Zhang W
    Emerg Microbes Infect; 2012 Jul; 1(7):e5. PubMed ID: 26038418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of genotypic and phenotypic resistance to second-line anti-tuberculosis drugs on treatment outcomes in multidrug-resistant tuberculosis in China.
    Hu Y; Zheng X; Ning Z; Li Q; Zhang Z; Hoffner S
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S34-S35. PubMed ID: 28043597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of novel Mycobacterium tuberculosis pncA gene mutations in clinical isolates from the Ukraine.
    Daum LT; Konstantynovska OS; Solodiankin OS; Poteiko PI; Bolotin VI; Rodriguez JD; Gerilovych AP; Chambers JP; Fischer GW
    Diagn Microbiol Infect Dis; 2019 Apr; 93(4):334-338. PubMed ID: 30583880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis.
    Whitfield MG; Soeters HM; Warren RM; York T; Sampson SL; Streicher EM; van Helden PD; van Rie A
    PLoS One; 2015; 10(7):e0133869. PubMed ID: 26218737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.
    Alame-Emane AK; Xu P; Pierre-Audigier C; Cadet-Daniel V; Shen X; Sraouia M; Siawaya JF; Takiff H; Gao Q; Gicquel B
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):679-84. PubMed ID: 25946359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Mutations in
    Shrestha D; Maharjan B; Thapa J; Akapelwa ML; Bwalya P; Chizimu JY; Nakajima C; Suzuki Y
    Curr Issues Mol Biol; 2022 Sep; 44(9):4132-4141. PubMed ID: 36135195
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Kim NY; Kim DY; Chu J; Jung SH
    Infect Chemother; 2023 Jun; 55(2):247-256. PubMed ID: 37407242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis.
    Kuhlin J; Davies Forsman L; Mansjö M; Jonsson Nordvall M; Wijkander M; Wagrell C; Jonsson J; Groenheit R; Werngren J; Schön T; Bruchfeld J
    Clin Infect Dis; 2021 Nov; 73(9):e3511-e3517. PubMed ID: 33011791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of
    Li K; Yang Z; Gu J; Luo M; Deng J; Chen Y
    Front Microbiol; 2020; 11():594171. PubMed ID: 33505367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings.
    Said HM; Kushner N; Omar SV; Dreyer AW; Koornhof H; Erasmus L; Gardee Y; Rukasha I; Shashkina E; Beylis N; Kaplan G; Fallows D; Ismail NA
    PLoS One; 2016; 11(1):e0146106. PubMed ID: 26752297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic surveillance and outcomes of pyrazinamide and fluoroquinolones-resistant tuberculosis in Taiwan.
    Huang HT; Lin WH; Chan TH; Jou R
    J Microbiol Immunol Infect; 2023 Dec; 56(6):1236-1244. PubMed ID: 37690869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiologic Correlates of Pyrazinamide-Resistant Mycobacterium tuberculosis in New York City.
    Verdugo D; Fallows D; Ahuja S; Schluger N; Kreiswirth B; Mathema B
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6140-50. PubMed ID: 26195530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population-Based Drug Resistance Surveillance of Multidrug-Resistant Tuberculosis in Taiwan, 2007-2014.
    Chuang PH; Wu MH; Fan SY; Lin KY; Jou R
    PLoS One; 2016; 11(11):e0165222. PubMed ID: 27846235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Investigation of pyrazinamide resistance in multidrug-resistant tuberculosis cases in Hospital of Pulmonary Diseases, Izmir, Turkey].
    Senol G; Coşkun M; Gündüz AT; Biçmen C; Gayaf M; Ozsöz A
    Mikrobiyol Bul; 2008 Oct; 42(4):591-7. PubMed ID: 19149080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing drug resistance of Mycobacterium tuberculosis isolates in a medical center in northern Taiwan.
    Su WJ; Feng JY; Huang CC; Perng RP
    J Formos Med Assoc; 2008 Mar; 107(3):259-64. PubMed ID: 18400612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance To First-Line Antituberculosis Drugs And Prevalence Of
    Cao Z; Lan Y; Chen L; Xiang M; Peng Z; Zhang J; Zhang H
    Infect Drug Resist; 2019; 12():3093-3102. PubMed ID: 31686870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.